Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 1.370
0.00 (0.00%)
At close: Sep 8, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 43.26 million as of September 18, 2026. Its market cap has increased by 44.33% in one year.
Market Cap
43.26M
Enterprise Value
46.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.37
ChartMarket Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has decreased from 62.09M to 43.26M, a decrease of -30.32%. That is a compound annual growth rate of -19.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 43.26M | -42.35% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 57.84M |
| ME Therapeutics Holdings | 53.18M |
| BriaCell Therapeutics | 51.42M |
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Microbix Biosystems | 41.09M |
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 39.23M |